-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Biomarin Pharmaceutical Inc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
- Biomarin Pharmaceutical Inc Costs and Expenses for the quarter ending March 31, 2024 was $560 M, a 4.94% increase year-over-year.
- Biomarin Pharmaceutical Inc Costs and Expenses for the twelve months ending March 31, 2024 was $2.29 B, a 9.01% increase year-over-year.
- Biomarin Pharmaceutical Inc annual Costs and Expenses for 2023 was $2.26 B, a 16.2% increase from 2022.
- Biomarin Pharmaceutical Inc annual Costs and Expenses for 2022 was $1.95 B, a 0.93% increase from 2021.
- Biomarin Pharmaceutical Inc annual Costs and Expenses for 2021 was $1.93 B, a 1.3% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)